Literature DB >> 16433729

Validity of transdermal alcohol monitoring: fixed and self-regulated dosing.

Joseph T Sakai1, Susan K Mikulich-Gilbertson, Robert J Long, Thomas J Crowley.   

Abstract

BACKGROUND: To study the validity of transdermal assessment of alcohol concentration measured by a lightweight, noninvasive device.
METHODS: Subjects wore a 227-g anklet that sensed transdermal alcohol concentrations (TACs) every 15 to 30 minutes, downloading results to a remote computer each day. Twenty-four subjects entered a laboratory and received a dose of 0, 0.28, or 0.56 g/kg of ethanol. Breath alcohol concentrations (BrAC) and TAC were measured every 15 to 30 minutes Twenty others [10 alcohol dependent (AD) and 10 not (NAD)] in the community who wore the anklet for 8 days kept a drinking log and provided a BrAC sample each day.
RESULTS: In the laboratory, no zero-dose subject, and every subject receiving alcohol, had alcohol-positive TACs. The device distinguished low- and high-alcohol-dosing groups using peak (t14 = 3.37; p < 0.01) and area under the curve (t14 = 3.42; p < 0.01) of TACs. Within dosing groups, average TAC curves were broader (right-shifted) and had lower peaks than average BrAC curves. For community participants, self-reported number of drinks (t18 = -3.77; p < 0.01), area under the TAC curve (t9.5 = -3.56; p < 0.01), and mean TAC (t9.9 = -3.35; p < 0.01) all significantly distinguished the AD and NAD groups. However, individual transdermal readings were not reliably quantitatively equivalent to simultaneously obtained breath results.
CONCLUSIONS: Within the limits of the laboratory study, the device consistently detected consumption of approximately 2 standard drinks. On average, the device shows discriminative validity as a semiquantitative measure of alcohol consumption but individual readings often are not equivalent to simultaneous BrACs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433729     DOI: 10.1111/j.1530-0277.2006.00004.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  44 in total

1.  Estimating BrAC from transdermal alcohol concentration data using the BrAC estimator software program.

Authors:  Susan E Luczak; I Gary Rosen
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

2.  Responses to alcohol and cigarette use during ecologically assessed drinking episodes.

Authors:  Thomas M Piasecki; Phillip K Wood; Saul Shiffman; Kenneth J Sher; Andrew C Heath
Journal:  Psychopharmacology (Berl)       Date:  2012-04-27       Impact factor: 4.530

Review 3.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

4.  Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.

Authors:  Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2017-12-05       Impact factor: 3.455

Review 5.  Assessment of Alcohol Use in the Natural Environment.

Authors:  Thomas M Piasecki
Journal:  Alcohol Clin Exp Res       Date:  2019-03-01       Impact factor: 3.455

6.  Experiences with SCRAMx alcohol monitoring technology in 100 alcohol treatment outpatients.

Authors:  Sheila M Alessi; Nancy P Barnett; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2017-06-28       Impact factor: 4.492

7.  Objective continuous monitoring of alcohol consumption for three months among alcohol use disorder treatment outpatients.

Authors:  Sheila M Alessi; Nancy P Barnett; Nancy M Petry
Journal:  Alcohol       Date:  2019-01-31       Impact factor: 2.405

8.  Wearable Electrochemical Alcohol Biosensors.

Authors:  Alan S Campbell; Jayoung Kim; Joseph Wang
Journal:  Curr Opin Electrochem       Date:  2018-05-23

9.  Time Delays in Transdermal Alcohol Concentrations Relative to Breath Alcohol Concentrations.

Authors:  Tara E Karns-Wright; John D Roache; Nathalie Hill-Kapturczak; Yuanyuan Liang; Jillian Mullen; Donald M Dougherty
Journal:  Alcohol Alcohol       Date:  2016-08-13       Impact factor: 2.826

10.  Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.

Authors:  Martin A Javors; Nathalie Hill-Kapturczak; John D Roache; Tara E Karns-Wright; Donald M Dougherty
Journal:  Alcohol Clin Exp Res       Date:  2016-04-30       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.